Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
₹ 25
Key Takeaways
Risk factor
Very high price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Very low or no dividends
Data is available to registered users only
Data is available to registered users only
About
Emmessar Biotech & Nutrition Ltd. engages in the manufacture and marketing of healthcare and nutritional products. The company operates through the following segments: Healthcare, Fine Chemicals, and Rent on Lease Land. It sells products for skin cure and care, general health, muscle and bone care, pain relief, and sexual health. The company was founded by Mathurakavi Srinivas Raghavan Ayyangar on March 17, 1992 and is headquartered in Mumbai, India.
Company Valuation
Based on key historical and expected multiples, the stock is overvalued relative to its peers. In particular, the stock is reasonably priced on P/E, 'expensive' on EV/EBI
Data is available to registered users only
